JP2017508734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508734A5 JP2017508734A5 JP2016551165A JP2016551165A JP2017508734A5 JP 2017508734 A5 JP2017508734 A5 JP 2017508734A5 JP 2016551165 A JP2016551165 A JP 2016551165A JP 2016551165 A JP2016551165 A JP 2016551165A JP 2017508734 A5 JP2017508734 A5 JP 2017508734A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- isolated peptide
- amino acid
- pharmaceutical composition
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461939561P | 2014-02-13 | 2014-02-13 | |
| US61/939,561 | 2014-02-13 | ||
| PCT/CA2015/000078 WO2015120536A1 (en) | 2014-02-13 | 2015-02-13 | Peptides that block leukocyte recruitment and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020000282A Division JP6994054B2 (ja) | 2014-02-13 | 2020-01-06 | 白血球動員をブロックするペプチドおよび使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017508734A JP2017508734A (ja) | 2017-03-30 |
| JP2017508734A5 true JP2017508734A5 (enExample) | 2018-03-29 |
| JP6673837B2 JP6673837B2 (ja) | 2020-03-25 |
Family
ID=53774369
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016551165A Active JP6673837B2 (ja) | 2014-02-13 | 2015-02-13 | 白血球動員をブロックするペプチドおよび使用方法 |
| JP2020000282A Active JP6994054B2 (ja) | 2014-02-13 | 2020-01-06 | 白血球動員をブロックするペプチドおよび使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020000282A Active JP6994054B2 (ja) | 2014-02-13 | 2020-01-06 | 白血球動員をブロックするペプチドおよび使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9464114B2 (enExample) |
| EP (1) | EP3105245B1 (enExample) |
| JP (2) | JP6673837B2 (enExample) |
| AU (1) | AU2015218198B2 (enExample) |
| CA (1) | CA2939266C (enExample) |
| ES (1) | ES2891174T3 (enExample) |
| WO (1) | WO2015120536A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7054674B2 (ja) * | 2015-08-11 | 2022-04-14 | アーチ バイオパートナーズ， インコーポレイテッド | Ｄｐｅｐ－１結合組成物および使用の方法 |
| AU2019386379B2 (en) * | 2018-11-30 | 2025-05-22 | Arch Biopartners, Inc. | DPEP-1 binding agents and methods of use |
| EP4574146A1 (en) | 2023-12-18 | 2025-06-25 | Telara Pharma S.L. | Dhp-i inhibitors for use as neuroprotectants and in the treatment of neuroinflammatory diseases |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244946A (en) | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
| US4305872A (en) | 1979-10-19 | 1981-12-15 | Kenneth Wingrove | Polypeptide derivatives |
| US4316891A (en) | 1980-06-14 | 1982-02-23 | The Salk Institute For Biological Studies | Extended N-terminal somatostatin |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5629179A (en) | 1995-03-17 | 1997-05-13 | Novagen, Inc. | Method and kit for making CDNA library |
| US5766905A (en) | 1996-06-14 | 1998-06-16 | Associated Universities Inc. | Cytoplasmic bacteriophage display system |
| BR0009804A (pt) * | 1999-04-16 | 2002-04-16 | Childrens Medical Center | Peptìdeos moduladores de adesão e seus usos |
| CN1323723C (zh) * | 2003-12-26 | 2007-07-04 | 上海新世界基因技术开发有限公司 | Tie2受体介导的靶向性肿瘤基因治疗的基因转移系统 |
| WO2006134960A1 (ja) * | 2005-06-16 | 2006-12-21 | Shionogi & Co., Ltd. | 抗炎症剤のスクリーニング方法 |
| WO2007146188A2 (en) * | 2006-06-07 | 2007-12-21 | The Board Of Trustees Of The Leland Stanford Junior University | Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| EP2196212A4 (en) * | 2007-10-04 | 2012-01-25 | Josai University Corp | PREPARATION AND METHOD FOR THE ADMINISTRATION OF A VACCINE AND IONTOPHORESE DEVICE WITH THE PREPARATION |
| WO2010099084A2 (en) * | 2009-02-27 | 2010-09-02 | Monsanto Technology Llc | Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules |
| WO2011119484A1 (en) * | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
-
2015
- 2015-02-13 WO PCT/CA2015/000078 patent/WO2015120536A1/en not_active Ceased
- 2015-02-13 CA CA2939266A patent/CA2939266C/en active Active
- 2015-02-13 US US14/622,177 patent/US9464114B2/en active Active
- 2015-02-13 ES ES15749560T patent/ES2891174T3/es active Active
- 2015-02-13 AU AU2015218198A patent/AU2015218198B2/en active Active
- 2015-02-13 JP JP2016551165A patent/JP6673837B2/ja active Active
- 2015-02-13 EP EP15749560.7A patent/EP3105245B1/en active Active
-
2016
- 2016-08-31 US US15/253,048 patent/US20170072006A1/en not_active Abandoned
-
2018
- 2018-09-13 US US16/129,942 patent/US11083773B2/en active Active
-
2020
- 2020-01-06 JP JP2020000282A patent/JP6994054B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019222918B2 (en) | Antimicrobial peptides and methods of use thereof | |
| US12162915B2 (en) | Cell penetrating peptides that inhibit IRF5 nuclear localization | |
| ES2842210T3 (es) | 4F-benzoil-TN14003 para la movilización de células progenitoras hematopoyéticas con vistas al trasplante | |
| JP2010518079A5 (enExample) | ||
| JP2013501816A5 (enExample) | ||
| JP2020501550A5 (enExample) | ||
| NZ591130A (en) | Compositions comprising a PD-1 antagonists and cyclophosphamide and methods of use thereof | |
| CN106188271B (zh) | 细胞凋亡抑制剂及其用途 | |
| JP2021509916A5 (enExample) | ||
| Spiller et al. | Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice | |
| JP2015502389A5 (enExample) | ||
| US20250002854A1 (en) | Methods of generating populations of tumour-infiltrating t cells | |
| JP2019527676A5 (enExample) | ||
| JP2009534451A5 (enExample) | ||
| JP2018528263A5 (enExample) | ||
| JP2022509258A5 (enExample) | ||
| JP2018035112A (ja) | 抗癌剤の抗腫瘍効果の増強剤、癌治療剤、及び癌治療用医薬組成物。 | |
| JP6994054B2 (ja) | 白血球動員をブロックするペプチドおよび使用方法 | |
| JP2021534184A5 (enExample) | ||
| JP2010533660A5 (enExample) | ||
| US20240226306A1 (en) | Trem-2/dap-12 inhibitors for treating lung disease and injury and combinations thereof | |
| CN106674329B (zh) | 具备抗微生物、抗癌/促进伤口愈合活性的肽及其用途 | |
| Hilchie et al. | The application of cationic antimicrobial peptides in cancer treatment: laboratory investigations and clinical potential | |
| JP2018512844A5 (enExample) | ||
| US20170368137A1 (en) | Modified Fragments From The Octarepeat Region Of Prion Protein As Hemin Binders |